Literature DB >> 26660737

Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline is Regulated by Different Cancer Stem Cell Populations.

Jo Meagan Garner, David W Ellison, David Finkelstein, Debolina Ganguly, Ziyun Du, Michelle Sims, Chuan He Yang, Rodrigo B Interiano, Andrew M Davidoff, Lawrence M Pfeffer.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0125838.].

Entities:  

Year:  2015        PMID: 26660737      PMCID: PMC4686089          DOI: 10.1371/journal.pone.0145052

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Fig 5 is incorrect. There are duplicated panels. The authors have provided a corrected version here.
Fig 5

Pathologic analysis of orthotopic GBM6 tumor xenografts.

GBM6 bulk tumor cells, Ad-GSCs and Sp-GSCs were orthotopically injected as described in Fig 4, and tumor-bearing brains were paraffin embedded for histology. A. H&E staining and B. Immunoreactivity for GFAP, S100, OLIG2 and MAP2. (All photomicrographs taken at 200x).

Pathologic analysis of orthotopic GBM6 tumor xenografts.

GBM6 bulk tumor cells, Ad-GSCs and Sp-GSCs were orthotopically injected as described in Fig 4, and tumor-bearing brains were paraffin embedded for histology. A. H&E staining and B. Immunoreactivity for GFAP, S100, OLIG2 and MAP2. (All photomicrographs taken at 200x).
  1 in total

1.  Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.

Authors:  Jo Meagan Garner; David W Ellison; David Finkelstein; Debolina Ganguly; Ziyun Du; Michelle Sims; Chuan He Yang; Rodrigo B Interiano; Andrew M Davidoff; Lawrence M Pfeffer
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

  1 in total
  1 in total

1.  Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease.

Authors:  Irfete S Fetahu; Dingailu Ma; Kimberlie Rabidou; Christian Argueta; Michael Smith; Hang Liu; Feizhen Wu; Yujiang G Shi
Journal:  Sci Adv       Date:  2019-08-28       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.